International organizations have united on critical recommendations to combat antimicrobial resistance in a ground-breaking report released today.
In a new review of the condition, experts from NIAID have called for a galvanized research response to growing cases of acute flaccid myelitis.
Economist, Lord Jim O’Neill, has suggested that nationalized or state-run drug companies could be the answer to the lack of investment in antibiotic development.
The UN High Level Meeting (UNHLM) on tuberculosis (TB) – a potential turning point to end the world’s leading infectious killer
Dr. Suvanand Sahu, Deputy Executive Director, at the Stop TB Partnership, reflects on the UNHLM on TB outlining the progress that was made and what more needs to be done.
The WHO has released a Global Influenza Strategy for 2019–2030 aiming to prevent seasonal flu, prepare for a pandemic situation and control the spread of zoonotic influenza.
The World Health Organization has released a new Technical Note updating countries worldwide on optimal methods and diagnostic techniques to improve antimicrobial resistance surveillance.
The UK’s Health & Social Care Select Committee has concluded that antimicrobial resistance should be established as a ‘top five policy priority’ for the UK Government.
The Joint Committee on Vaccination and Immunisation has stated that a gender-neutral vaccine program would be cost effective in the UK and would protect boys against HPV infection and associated diseases.
In this interview Sally, a Senior Research Fellow at Imperial College London’s Faculty of Medicine (London, UK), speaks about her work on issues relating to the vaccination and screening of migrants, in addition to discussing some of the wider issues facing migrant’s access to healthcare in Europe.
Population mobility and infectious diseases and infectious diseases and population mobility – direction really does matter?
Infectious diseases and population mobility are intimately linked from the perspectives of clinical practice to global health policy. Mobility bridges significant epidemiological differences in the classical determinants of health for all diseases. The new reality is that “surveillance, detection and response” activities in infectious diseases clinical care and public health are the responsibility all members of society.